BioClinica, Inc. (BIOC) Releases OnPoint Platform, Notes Increased Industry Demand
BioClinica, Inc., a global provider of clinical trial management solutions (CTMS), today announced the release of its BioClinica OnPoint platform, which it acquired from TranSenda in 2010. The company highlighted industry trends migrating toward collaborative technology that can be integrated with existing systems. “A quiet transformation of clinical study architectures is occurring in the industry through the increased use of standard collaboration tools for clinical study management and regulatory document management,” Gartner Research Vice President Steve Lefebure stated in the press release. “Life science companies are seeking to leverage existing infrastructure, support collaboration, and create flexibility. Solutions that leverage both…